GlycoNex Competitors and Similar CompaniesClear all
CytomX Therapeutics's competitors and similar companies include Oncopeptides.
 CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | ||
Founding Date | Founding Date 2008 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US |
Employees | Employees 15815% increase | Employees 80 |
Valuation ($) | Valuation ($) 78 m | Valuation ($) 42.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $76.2m (FY, 2025) | Revenue (est.) kr71.1m (FY, 2025) |
Net income | Net income ($17.4m) (FY, 2025) | Net income (kr249.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company